Genomic alterations in CDK12 have been observed in multiple cancers, exhibiting both pro-tumorigenic and tumor-suppressive functions, suggesting a context-dependent mechanism of action.<h4>Methods</h4>CDK12 copy number alterations and gene expression levels were analyzed in matched primary and brain metastatic patient tumors. Here, CDK12 is linked to neoplasm.